Ctc Bio, Inc.

Samsung Sdi Co., Inc.

Ferring B.v.

Su-Jun Park

Bong-Sang Lee

Do-Woo Kwon

Hong Ryeol Jeon

Hong-Ryeol Jeon

Jiyeong Han

Myeongcheol Kil

Min Seop Kim

Jun-Ki Kim

Bong-Geun Cha

In-Seob Song

Dong-Rak Kim

Jun-Young Kim

Jong-Rock Choi

Hwa-Su Kim

Seong-Shin Kwak

Jeong-Kurn Park

Kwang-Min Yoo

Cheol-Gi Son

Hyun-Jun Do

Seul Ki Meang

Ji-yeong Han

Bong Sang Lee

Myeong-Cheol Kil

The present disclosure relates to an orally administered pharmaceutical formulation containing an inclusion complex formed as varenicline or a pharmaceutically acceptable salt thereof is included in cyclodextrin. The pharmaceutical formulation can improve convenience of medication by effectively masking the bitter taste of the drug and the irritation during swallowing, can provide the oxidation stability of varenicline and can improve the solubility of the drug.

Preparation, comprising inclusion complex of varenicline or pharmaceutically acceptable salt thereof, for oral administration

The present disclosure relates to a film formulation for oral administration, containing tadalafil free base and a method of preparing the same, and a film may be provided with maximized dispersion stability of tadalafil free base in the film by the addition of a dispersion stabilizing agent in small amounts without unique fragrance or favor that may appear when other dispersion stabilizing agents known in the art are used, and an extremely low likelihood that a reagglomeration phenomenon of tadalafil free base particles will occur, and an amount of bubbles generated may be significantly reduced during a production process.

Tadalafil free base-containing film dosage form containing polyethylene glycol-based polymer and/or vinyl pyrrolidone-based polymer as dispersion stabilizer

A battery pack includes a first battery with a first capacity, a second battery with a second capacity less than the first capacity, and a variable resistor. The second battery has a larger maximum discharge current than the first battery. The variable resistor circuit limits the discharge current of the first battery to a predetermined limit current value.

Battery pack

The present invention relates to a pharmaceutical preparation for oral administration comprising, as an active ingredient, clomipramine or a pharmaceutically acceptable salt thereof; and a cation exchange resin and an anion polymer as a taste masking agent, wherein the pharmaceutical preparation can be orally administered even while comprising a pharmaceutically effective amount of clomipramine because the unique tastes of clomipramine, particularly, all of the bitter taste, spicy taste and burning taste are effectively masked, and thus the convenience of drug intake and portability is improved, and a method for manufacturing thereof.

Pharmaceutical preparation for masked taste oral administration, containing clomipramine

The present invention relates to a pharmaceutical preparation comprising entecavir as an active ingredient, wherein an antioxidizing agent is added to enhance stability of entecavir, and a method for preparing the same. According to the present invention, the invention has an effect that entecavir can be stably maintained in a pharmaceutical preparation containing a certain amount or more of moisture by adding the antioxidizing agent, thereby a pharmaceutical preparation can be provided as a formulation containing a certain amount or more of moisture, for example, an orally disintegrating film formulation.

Pharmaceutical preparation containing entecavir as active ingredient, and preparation method therefor

The present invention provides a method for preparing a film comprising a high amount of a sildenafil free base uniformly dispersed therein and having a suitable thickness and size, as well as flexibility providing good handling stability and being not prone to breaking. The present invention also provides a sildenafil free base-containing film prepared from the method.

Sildenafil-free base-containing film preparation and method for producing same

The present invention provides choline alfoscerate-containing pharmaceutical preparations which have improved storage-stability and are easily taken. The present invention also provides a method for manufacturing pharmaceutical preparations comprising choline alfoscerate, which is easy and simple and is performed by normal manufacturing equipments.

Pharmaceutical formulation containing choline alfoscerate

Growing community of inventors

Gyeonggi-do, South Korea

Su-Jun Park